Name

Bryostatin

Alternate Names

B705008K112
Bryostatin-1

Abbreviations

None

Category

Chemotherapy

Subcategory

Protein kinase activator

NSC Number

339555

Primary Site

Breast
cervical
esophageal
gastric
head & neck
kidney
leukemia
metastatic solid tumors
ovarian
prostate cancer

Histology

None

Remarks

Used to treat a variety of malignancies including sarcomas, lymphomas, leukemias, breast, colon and lung cancers. No information on FDA approval to treat these neoplasms as of April 2024.

Coding

This drug should be coded
Glossary